Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡Markus Cornberg, Heiner Wedemeyer, Norah A. Terrault et al.|Journal of Hepatology|2019Cited by 364